Paid Clinical Trials in Nottingham, Nottinghamshire for Healthy Volunteers
Nottingham, Nottinghamshire has 4 clinical trials actively recruiting healthy volunteers. These include Phase 1 drug safety studies, bioequivalence trials, vaccine studies, and observational research — most offering financial compensation for participation. Learn which studies pay the most →
Showing 1–4 of 4 studies
A Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, and to Explore the Effect of Food After Multiple Doses of Selected Prototypes in Healthy Adult Participants
Non-invasive Ultrasonic Auricular Vagus Nerve Stimulation
A Study to Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy Participants
The Combined Effect of Dietary Nitrate and Caloric Restriction on Cognitive and Vascular Function.
Common questions about trials in Nottingham, Nottinghamshire
How many paid clinical trials are recruiting healthy volunteers in Nottingham, Nottinghamshire?
There are currently 4 clinical trials actively recruiting healthy volunteers in Nottingham, Nottinghamshire. This number updates daily as new studies open and existing studies complete enrollment.
How much do clinical trials pay in Nottingham, Nottinghamshire?
Compensation varies by study type and duration. Phase 1 inpatient studies typically pay $1,000–$5,000+, outpatient visits may pay $50–$500 each, and bioequivalence studies often pay $1,000–$5,000. Each study listing includes specific compensation details in the consent form.
What types of healthy volunteer studies are available in Nottingham, Nottinghamshire?
Common study types include Phase 1 drug safety trials, bioequivalence studies comparing generic and brand-name drugs, vaccine trials, dietary and nutrition studies, and observational research. All listed studies are registered on public registries and approved by ethics committees.
Do I need health insurance to participate?
No. Healthy volunteer studies cover all study-related medical costs. If an adverse event occurs, the trial sponsor is generally responsible for related treatment. Specifics are outlined in each study's informed consent document.